Biotech

All Articles

Analysts go into Avidity's DMD win, uncovering subtleties in data

.Avidity Biosciences amazed real estate investors along with stage 1/2 information in Duchenne muscl...

Actinogen's cortisol blocker fails stage 2 depression research

.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a period 2 research in d...

Bivictrix determines going personal only method to take ADC into center

.Antibody-drug conjugates (ADCs) have been at the facility of numerous a billion-dollar biobuck lice...

TPG bests up funds to $580M for assets throughout lifestyle sciences

.Asset manager TPG, which has assisted biotechs including Sionna Rehabs as well as Santa Clam Ana Bi...

Merck stops period 3 TIGIT trial in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT program has suffered one more problem. Months after shuttering a stage 3 mos...

After a tough year, Exscientia folds into Recursion

.After a year specified through pipe hairstyles, the shift of its CEO and layoffs, Exscientia will d...

Cullinan, after $25M package, return bispecific to Port

.Cullinan Therapeutics was impressed enough along with Harbour BioMed's bispecific invulnerable acti...

A better check out Tough Biotech's Strong 15

.In this particular week's incident of "The Top Pipe," our team're diving in to Ferocious Biotech's ...

Lilly encounters stage 2 breakdown of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event commemorating the commendation ...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, firings as w...